Quarterly report [Sections 13 or 15(d)]

Schedule of Segment Information (Details)

v3.26.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Consolidated net revenue $ 1,011 $ 1,247 $ 2,180 $ 2,678  
Consolidated cost of revenue 785 513 1,659 1,418  
Total Depreciation and amortization expense 623 1,010 1,245 2,151  
Total operating and other expenses 2,642 3,417 6,116 7,480  
Total loss from operations, before income taxes (3,039) (3,693) (6,840) (8,371)  
Income tax expense (12) (779) (1,386) (779)  
Total loss from operations, after income taxes (3,051) (4,472) (8,226) (9,150)  
Net loss from continuing operations (3,051) (4,472) (8,226) (9,150)  
Unallocated corporate 57,409   57,409   $ 59,871
Total assets 57,409   57,409   59,871
Diagnostic Services Segment [Member]          
Segment Reporting [Line Items]          
Consolidated net revenue  
Consolidated cost of revenue 112 344  
Total Depreciation and amortization expense 205 539  
Total operating and other expenses 1,560 1,728  
Total loss from operations, before income taxes (1,877) (2,611)  
Consumer Products Segment [Member]          
Segment Reporting [Line Items]          
Consolidated net revenue 1,011 1,247 2,180 2,678  
Consolidated cost of revenue 785 401 1,659 1,074  
Total Depreciation and amortization expense 623 805 1,245 1,612  
Total operating and other expenses 760 211 1,271 1,272  
Total loss from operations, before income taxes (1,157) (170) (1,995) (1,280)  
Unallocated corporate 10,309   10,309   11,614
Unallocated Corporate [Member]          
Segment Reporting [Line Items]          
Total operating and other expenses 1,882 1,646 4,845 4,480  
Total loss from operations, before income taxes (1,882) $ (1,646) (4,845) $ (4,480)  
Unallocated corporate $ 47,100   $ 47,100   $ 48,257